CABA - Cabaletta Bio Inc
1.16
0.010 0.862%
Share volume: 386,721
Last Updated: 05-07-2025
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
-0.02%
PREVIOUS CLOSE
CHG
CHG%
$1.15
0.01
0.01%
View ratios
| Fiscal Date | 03-31-2023 | 06-30-2023 | 09-30-2023 | 12-31-2023 | 03-31-2024 | 06-30-2024 | 09-30-2024 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | |
| Report Date | 05-15-2024 | 08-10-2023 | 11-09-2023 | 11-14-2024 | 05-15-2024 | 08-08-2024 | 11-14-2024 | |
| Total revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| nan% | nan% | nan% | nan% | nan% | ||||
| Operating expenses | 16.956 M | 15.890 M | 18.668 M | 23.146 M | 28.031 M | 30.279 M | 33.046 M | |
| Selling general and admin | 4.521 M | 4.093 M | 4.881 M | 5.741 M | 6.077 M | 6.852 M | 6.756 M | |
| Research and development | 12.435 M | 11.797 M | 13.787 M | 17.405 M | 21.954 M | 23.427 M | 26.290 M | |
| Total expenses | 16.956 M | 15.890 M | 18.668 M | 23.146 M | 28.031 M | 30.279 M | 33.046 M | |
| -6.29% | 17.48% | 23.99% | 21.11% | 8.02% | 9.14% | |||
| Operating income | -16.956 M | -15.890 M | -18.668 M | -23.146 M | -28.031 M | -30.279 M | -33.046 M | |
| Ebit | -16.956 M | -15.890 M | -18.668 M | -23.146 M | -28.031 M | -30.279 M | -33.046 M | |
| Pretax income | -15.854 M | -14.487 M | -16.448 M | -20.886 M | -25.047 M | -27.602 M | -30.629 M | |
| -8.62% | 13.54% | 26.98% | 19.92% | 10.20% | 10.97% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | -15.854 M | -14.487 M | -16.448 M | -20.886 M | -25.047 M | -27.602 M | -30.629 M | |
| 8.62% | -13.54% | -26.98% | -19.92% | -10.20% | -10.97% |
